Healthspan Economy

ClinicalTrials.gov · NCT07475546 · Completed

Combination Gerotherapeutic Interventions for Healthspan Improvement

Registry record

NCT07475546 on ClinicalTrials.gov. The registry's last update to this record was 30 October 2026.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Combination Gerotherapeutic Interventions for Healthspan Improvement Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor AgelessRx Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Rapamycin; Naltrexone; Metformin; NAD+; GSH; Infinite Supplement; Placebo/control; B12 Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Change in cardiorespiratory fitness measured by maximal oxygen uptake (VO₂ max) | Change in cognitive performance measured by Creyos Cognitive Test | Change in systemic chronic inflammation measured by iAge index score | Change in lean body mass measured by dual-energy X-ray absorptiometry (DEXA) Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Completed Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-10-30. Checked

Check history: NCT07475546 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: AgelessRx
  • Phase: Phase 3
  • Status: Completed
  • Intervention: Rapamycin; Naltrexone; Metformin; NAD+; GSH; Infinite Supplement; Placebo/control; B12
  • Primary outcome: Change in cardiorespiratory fitness measured by maximal oxygen uptake (VO₂ max) | Change in cognitive performance measured by Creyos Cognitive Test | Change in systemic chronic inflammation measured by iAge index score | Change in lean body mass measured by dual-energy X-ray absorptiometry (DEXA)
  • Countries: United States
  • Start: 23 July 2025
  • Completion (actual): 9 April 2026

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

Related modality

A trial being registered is not evidence that the intervention works.